The journey from production line to patient: exploring the end-to-end requirements of a successful cold chain operation

While the clinical trial landscape is ever evolving with an increase in biologic drugs being trialed, the need to supply patients with safe, compliant IMP remains unaffected. Running globalised trials involving temperature sensitive products magnifies the need for sponsors to develop effective risk mitigations that safeguard product integrity and promote patient safety.

One of the most high-risk areas of managing such trials is the clinical cold chain; where failure to consider potential packaging, labelling, and distribution challenges can compromise a trial’s timing, safety, and commercial viability.

Download our latest article that explores the cold chain journey, from production line to patient, to learn how you can overcome challenges within your temperature controlled supply chain.